Drugs / OP-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00456157 | Mar 2007 → Nov 2008 | osteoarthritis, knee | Stryker Biotech | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OP-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00456157 ↗ |
| Known as | Osteogenic Protein-1 | “Intra-articular Osteogenic Protein-1 OP-1 in Subjects With Osteoarthritis of the Knee” NCT00456157 ↗ |
| Modality | Protein / enzyme biologic | “intra-articular recombinant human BMP-7 (bone morphogenetic protein-7)” PMID 20932341 ↗ Oct 2010 |
| Route | Other | “injected into the knee joint” NCT00456157 ↗ |